Methamphetamine drug abuse and addiction
The Journal of Dual Diagnosis: Open Access (ISSN:2472-5048) is going to Celebrate Four years of anniversary in the year 2020, It aims to disseminate knowledge and promote discussion through the publication of peer-reviewed, high quality research papers on all topics related to Dual diagnosis.
The Journal of Dual Diagnosis mainly focuses in the field of Substance Use Disorder, co-occurring disorders, dementia, Dual Diagnosis Treatment, Clinical Diagnosis of Depression, Autism Diagnosis, Alzheimer Diagnosis, Schizophrenia Diagnosis, Psychiatric Diagnosis, and Anxiety Diagnosis. It is an area of great interest for specialists in addiction medicine, as patients with dual diagnosis pose special diagnostic and management problems. It is of increasing interest to general psychiatrists, who although recognizing both disorders, may be frustrated in their management of them, especially if trying to treat these cases without the benefit of a multidisciplinary team.
Drugs of addiction, have been recognized as potential contaminants of concern to the environment. Effluent wastewater discharge is a major source of contamination to aquatic receiving environments.
The abnormal aging mechanism associated with drug abuse results in poor performance of face recognition systems on illicit drug addicts (mainly methamphetamine). Consequently, the high correlation between drug addiction and crime exaggerates the urge for further investigations to originate and overcome this problem. Concurrently, face asymmetry was found to play a significant role in face recognition and age estimation. Therefore, facial asymmetry assessment for meth-addicts is highly serviceable, acknowledging how meth addiction accelerates biological aging and causes severe face distortion.
The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication. A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be submitted through the Email given below.
You can Submit manuscript directly online https://www.imedpub.com/submissions/dual-diagnosis-open-access.html or as an attachment to this E-mail: email@example.com
Articles will be paid high attention during the Publication any immediate submission is highly appreciable.
Dual Diagnosis: Open Access
WhatsApp no: +1-947-333-4405